Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

European survey on national training activities in clinical research

A. Magnin, VC. Iversen, G. Calvo, B. Čečetková, O. Dale, R. Demlova, G. Blasko, F. Keane, GL. Kovacs, C. Levy-Marchal, EC. Monteiro, L. Palmisano, D. Pella, A. Portolés Pérez, O. Rascol, C. Schmid, F. Tay, H. von der Leyen, C. Ohmann,

. 2019 ; 20 (1) : 616. [pub] 20191029

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023577

BACKGROUND: Investigator-initiated clinical studies (IITs) are crucial to generate reliable evidence that answers questions of day-to-day clinical practice. Many challenges make IITs a complex endeavour, for example, IITs often need to be multinational in order to recruit a sufficient number of patients. Recent studies highlighted that well-trained study personnel are a major factor to conduct such complex IITs successfully. As of today, however, no overview of the European training activities, requirements and career options for clinical study personnel exists. METHODS: To fill this knowledge gap, a survey was performed in all 11 member and observer countries of the European Clinical Research Infrastructure Network (ECRIN), using a standardised questionnaire. Three rounds of data collection were performed to maximize completeness and comparability of the received answers. The survey aimed to describe the landscape of academic training opportunities, to facilitate the exchange of expertise and experience among countries and to identify new fields of action. RESULTS: The survey found that training for Good Clinical Practice (GCP) and investigator training is offered in all but one country. A specific training for study nurses or study coordinators is also either provided or planned in ten out of eleven countries. A majority of countries train in monitoring and clinical pharmacovigilance and offer specific training for principal investigators but only few countries also train operators of clinical research organisations (CRO) or provide training for methodology and quality management systems (QMS). Minimal requirements for study-specific functions cover GCP in ten countries. Only three countries issued no requirements or recommendations regarding the continuous training of study personnel. Yet, only four countries developed a national strategy for training in clinical research and the career options for clinical researchers are still limited in the majority of countries. CONCLUSIONS: There is a substantial and impressive investment in training and education of clinical research in the individual ECRIN countries. But so far, a systematic approach for (top-down) strategic and overarching considerations and cross-network exchange is missing. Exchange of available curricula and sets of core competencies between countries could be a starting point for improving the situation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023577
003      
CZ-PrNML
005      
20201214130444.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13063-019-3702-z $2 doi
035    __
$a (PubMed)31665085
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Magnin, A $u SCTO - Swiss Clinical Trial Organisation, Bern, Switzerland.
245    10
$a European survey on national training activities in clinical research / $c A. Magnin, VC. Iversen, G. Calvo, B. Čečetková, O. Dale, R. Demlova, G. Blasko, F. Keane, GL. Kovacs, C. Levy-Marchal, EC. Monteiro, L. Palmisano, D. Pella, A. Portolés Pérez, O. Rascol, C. Schmid, F. Tay, H. von der Leyen, C. Ohmann,
520    9_
$a BACKGROUND: Investigator-initiated clinical studies (IITs) are crucial to generate reliable evidence that answers questions of day-to-day clinical practice. Many challenges make IITs a complex endeavour, for example, IITs often need to be multinational in order to recruit a sufficient number of patients. Recent studies highlighted that well-trained study personnel are a major factor to conduct such complex IITs successfully. As of today, however, no overview of the European training activities, requirements and career options for clinical study personnel exists. METHODS: To fill this knowledge gap, a survey was performed in all 11 member and observer countries of the European Clinical Research Infrastructure Network (ECRIN), using a standardised questionnaire. Three rounds of data collection were performed to maximize completeness and comparability of the received answers. The survey aimed to describe the landscape of academic training opportunities, to facilitate the exchange of expertise and experience among countries and to identify new fields of action. RESULTS: The survey found that training for Good Clinical Practice (GCP) and investigator training is offered in all but one country. A specific training for study nurses or study coordinators is also either provided or planned in ten out of eleven countries. A majority of countries train in monitoring and clinical pharmacovigilance and offer specific training for principal investigators but only few countries also train operators of clinical research organisations (CRO) or provide training for methodology and quality management systems (QMS). Minimal requirements for study-specific functions cover GCP in ten countries. Only three countries issued no requirements or recommendations regarding the continuous training of study personnel. Yet, only four countries developed a national strategy for training in clinical research and the career options for clinical researchers are still limited in the majority of countries. CONCLUSIONS: There is a substantial and impressive investment in training and education of clinical research in the individual ECRIN countries. But so far, a systematic approach for (top-down) strategic and overarching considerations and cross-network exchange is missing. Exchange of available curricula and sets of core competencies between countries could be a starting point for improving the situation.
650    _2
$a biomedicínský výzkum $x výchova $7 D035843
650    12
$a klinické zkoušky jako téma $7 D002986
650    _2
$a kurikulum $7 D003479
650    _2
$a lidé $7 D006801
650    _2
$a klinická farmakologie $x výchova $7 D010601
650    _2
$a farmakovigilance $7 D060735
650    _2
$a výzkumní pracovníci $x výchova $7 D012108
650    _2
$a průzkumy a dotazníky $7 D011795
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Iversen, V Cabral $u NorCRIN - Norwegian Clinical Research Infrastructures Network, Trondheim, Norway.
700    1_
$a Calvo, G $u SCReN - Spanish Clinical Research Network, Madrid, Spain.
700    1_
$a Čečetková, B $u SLOVACRIN - Slovak Clinical Research Infrastructure Network, Bratislava, Slovakia.
700    1_
$a Dale, O $u NorCRIN - Norwegian Clinical Research Infrastructures Network, Trondheim, Norway.
700    1_
$a Demlova, R $u CZECRIN - Czech Clinical Research Infrastructure Network, Prague, Czech Republic.
700    1_
$a Blasko, Gy $u HECRIN - Hungarian Clinical Research Infrastructure Network, Budapest, Hungary.
700    1_
$a Keane, F $u HRB CRCI - Health Research board, Clinical Research Coordination Ireland, Dublin, Ireland.
700    1_
$a Kovacs, G L $u HECRIN - Hungarian Clinical Research Infrastructure Network, Budapest, Hungary.
700    1_
$a Levy-Marchal, C $u F-CRIN - French Clinical Research Infrastructure Network, Paris, France.
700    1_
$a Monteiro, E C $u PTCRIN - Portuguese Clinical Research Infrastructure Network, Lisboa, Portugal.
700    1_
$a Palmisano, L $u ItaCRIN - Italian Clinical Research Infrastructure Network, Rome, Italy.
700    1_
$a Pella, D $u SLOVACRIN - Slovak Clinical Research Infrastructure Network, Bratislava, Slovakia.
700    1_
$a Portolés Pérez, A $u SCReN - Spanish Clinical Research Network, Madrid, Spain.
700    1_
$a Rascol, O $u F-CRIN - French Clinical Research Infrastructure Network, Paris, France.
700    1_
$a Schmid, C $u SCTO - Swiss Clinical Trial Organisation, Bern, Switzerland.
700    1_
$a Tay, F $u SCTO - Swiss Clinical Trial Organisation, Bern, Switzerland.
700    1_
$a von der Leyen, H $u KKSN - Netzwerk der Koordinierungszentren für Klinische Studien, Hannover, Germany.
700    1_
$a Ohmann, C $u ECRIN - European Clinical Research Infrastructure Network, Kaiserswerther Str, 70 40477, Düsseldorf, Germany. Christian.Ohmann@med.uni-duesseldorf.de.
773    0_
$w MED00163187 $t Trials $x 1745-6215 $g Roč. 20, č. 1 (2019), s. 616
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31665085 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130443 $b ABA008
999    __
$a ok $b bmc $g 1595896 $s 1114253
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 1 $d 616 $e 20191029 $i 1745-6215 $m Trials $n Trials $x MED00163187
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...